Lucid Diagnostics Inc (LUCD)

Lucid Diagnostics Inc (LUCD) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $116M; returns 1 day +25.4%, 1 week -14.0%, 1 year -66.6%.

Lucid Diagnostics Inc. (LUCD) is a commercial-stage medical diagnostics company focused on preventing esophageal adenocarcinoma (EAC) by detecting Barrett's Esophagus (BE), a precancerous condition, using a non-endoscopic, office-based procedure.

Groups LUCD belongs to

• Healthcare
• Commercial Stage
• Health Diagnostics and Imaging
• Medical Devices
• Oncology
• Early Cancer Detection
• Healthcare Technology
• Healthcare Innovation
• Preventive Care
• Gastroenterology

LUCD financial model: income statement, cash flow and balance sheet